April Sena

April Sena, PhD, currently serves as Vice President of Technical Operations at Life Edit Therapeutics, where responsibilities include leading due diligence for potential acquisitions, setting company strategy for innovation, and providing CMC governance. Previously, April held various leadership roles at Seqirus, including Director of Global CMC and Research QA, where April oversaw quality operations for vaccine development and played a key role in the strategic planning and quality decision-making for Covid and influenza vaccines. Earlier experience includes positions at AstraZeneca and the Centers for Disease Control and Prevention, focusing on quality assurance, microbiology, and vaccine research. April earned a PhD in Molecular Genetics and Microbiology and a BS in Biology from Duke University.